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Mediator1: An Important  
Intermediary of Vitamin D  
Receptor–Regulated Epidermal 
Function and Hair Follicle Biology
Wendy B. Bollag1,2
Considerable data in the literature support the idea that 1,25-dihydroxyvitamin D3 
and the vitamin D receptor (VDR) are involved in regulating skin biology. Studies 
using cultured keratinocytes, artificial human skin, and transgenic mouse models, 
as well as observations in patients with rickets, provide evidence of this pathway’s 
importance in epidermal proliferation and differentiation and the hair growth 
cycle. The report by Oda et al. in this issue also indicates an important role of the 
VDR coactivator mediator 1 in these processes.
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Vitamin D can be obtained from the diet 
or produced in the skin from 7-dehydro-
cholesterol as the result of exposure to 
sunlight (UVR). This sterol must then be 
hydroxylated twice, in sequence at the 
25 and 1 positions, to form the active 
metabolite, 1,25-dihydroxyvitamin D3 
(1,25(OH)2D3). For the production of 
systemic 1,25(OH)2D3, the hydroxy 
group at the 25 position is added main-
ly in the liver, whereas the rate-limiting 
1a-hydroxylation reaction occurs in the 
kidney under control of the parathyroid 
hormone. The role of 1,25(OH)2D3 in 
the regulation of mineral homeostasis is 
well known. In addition to being the site 
for UV-induced generation of vitamin D, 
epidermal keratinocytes express both of 
the enzymes—vitamin D 25-hydroxy-
lase (CYP2R1) and 25-hydroxyvitamin D 
1a-hydroxylase (CYP27B1)—required for 
the production of active 1,25(OH)2D3. 
Thus, keratinocytes have the com-
plete machinery to produce the active 
metabolite of vitamin D upon expo-
sure of skin to UVR (reviewed in Bikle, 
2010). Moreover, these cells express the 
receptor for 1,25(OH)2D3, the vitamin 
D receptor (VDR). VDR is a nuclear hor-
mone receptor that heterodimerizes with 
the retinoid X receptor (RXR) to regu-
late transcription of genes that possess 
vitamin D response elements in their 
promoters (reviewed in Bollag, 2007). 
Several additional proteins are involved 
in VDR’s regulation of transcription, 
including coactivators such as mediator1 
(MED1) and steroid receptor coregulator 
2 (SRC2) and 3 (SRC3).
The importance of the vitamin D 
pathway in epidermal keratinocytes 
has been shown in mouse and human 
keratinocytes in culture (reviewed in 
Bikle, 2010). Such studies have shown 
that 1,25(OH)2D3, or its analogs, can 
inhibit keratinocyte proliferation and 
promote differentiation. Furthermore, 
decreasing the levels of members of the 
pathway (e.g., VDR or its coactivators) 
reduces keratinocyte differentiation in 
vitro (Amor et al., 2010). These results 
have been extended into artificial human 
epidermis (Hawker et al., 2007), in that 
knockdown of VDR, MED1 (referred to 
as vitamin D receptor–interacting protein 
205 or DRIP205 here), SRC2, or SRC3 
using adenovirus-delivered short hairpin 
RNAs resulted in reductions in various 
keratinocyte differentiation markers fol-
lowing generation of an epidermal-like 
structure in an advanced human kerati-
nocyte differentiating system (reviewed 
in Bollag, 2007). The presumed tran-
scription factor hairless interacts with 
the VDR and suppresses VDR-mediated 
transcription, and knockdown of hairless 
increases VDR-induced keratinocyte dif-
ferentiation (reviewed in Bikle, 2010).
Additional studies have shown the 
importance of the vitamin D pathway 
in regulating skin biology in vivo using 
transgenic mouse models. For example, 
VDR-null mutant mice exhibit reduced 
keratinocyte differentiation marker lev-
els in the interfollicular epidermis and 
hair loss that begins with the second 
hair cycle after birth (i.e., during post-
natal maintenance of the hair cycle 
rather than being initiated during the 
first cycle, which represents comple-
tion of embryologic development of the 
hair follicle) (Xie et al., 2002). This result 
may be attributable to the key role of 
the VDR in keratinocyte stem cell func-
tion (Cianferotti et al., 2007). Alopecia 
in the VDR knockout mice could not be 
prevented by a high-calcium diet that 
blocks the bone and mineral homeo-
stasis defects observed in these mice 
(Li et al., 1998). However, hair loss in 
the VDR-null mice was prevented by 
expression of keratinocyte-targeted VDR 
(Chen et al., 2001), even one with a 
mutation in the ligand-binding domain 
(Skorija et al., 2005). This finding sug-
gests that the effects of VDR in regulating 
hair follicle biology are ligand-indepen-
dent. On the other hand, restoration of 
VDR expression in keratinocytes using 
a construct with a mutation in the DNA 
binding domain did not prevent the alo-
pecia that results from global deletion of 
the VDR gene (Skorija et al., 2005).
The ligand independence of VDR 
with respect to its effects on hair follicle 
maintenance is further supported by 
the phenotype of transgenic mice lacking 
the gene encoding 25-hydroxyvitamin D 
1a-hydroxylase (CYP27B1), the enzyme 
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that generates active 1,25(OH)2D3. 
These mice do not develop alopecia, 
although they do exhibit reduced levels 
of keratinocyte differentiation mark-
ers in the interfollicular epidermis, as 
well as impaired permeability barrier 
homeostasis (Bikle et al., 2004). By 
contrast, spontaneous mutations in the 
VDR suppressor hairless (see above) 
in mice result in—as the gene name 
implies—hair loss (Xie et al., 2006). A 
hairless knockout mouse model also 
exhibits hair loss, as well as increased 
proliferation and enhanced expression 
of markers of keratinocyte differen-
tiation (Zarach et al., 2004). Ablation 
of the VDR heterodimer partner RXR 
in RXR-null mutant mice also largely 
reproduces the hair-loss phenotype of 
the VDR knockout mice (Li et al., 2001).
There is also evidence in humans of 
the importance of vitamin D and VDR 
in skin biology. 1,25(OH)2D3 and its 
analogs have been used successfully to 
treat psoriasis (Amor et al., 2010), a skin 
disorder characterized by keratinocyte 
hyperproliferation and abnormal differ-
entiation, inflammation, and vascular 
changes. As indicated earlier, the role of 
1,25(OH)2D3 in the regulation of min-
eral homeostasis and bone physiology 
is well known, and vitamin D deficiency 
results in rickets (i.e., weak bones). 
Similarly, mutations in VDR lead to an 
inherited form of rickets, type IIA vitamin 
D–dependent rickets. Patients with this 
form of rickets also exhibit alopecia, sug-
gesting the importance of the vitamin D 
pathway in regulating hair follicle biol-
ogy in humans (Amor et al., 2010).
In a study reported in this issue, Oda 
et al. generated a conditional knockout 
mouse model lacking the MED1 gene 
in the epidermis. MED1 is a coactivator 
known to interact with the VDR, and 
previous studies have shown its impor-
tance in responses initiated by VDR as 
well as in keratinocyte differentiation 
(Hawker et al., 2007). Oda et al. found 
that ablation of MED1 results in hair loss 
and increased proliferation, as well as 
elevated expression of differentiation 
markers in interfollicular epidermis. 
Although similar to the phenotype 
observed with the hairless knockout 
mouse model (Zarach et al., 2004), this 
latter finding was perhaps unexpected, 
but it points to possible unique actions 
of MED1 relative to its partner mol-
ecules within the vitamin D pathway. 
Again, the first developmental hair cycle 
was not affected, but later postnatal 
maintenance cycles were, suggesting 
the possibility that defects in MED1 
function may also contribute to alope-
cia in certain patient populations. The 
results from these various mouse models 
are summarized in Table 1.
There is an additional phenotypic char-
acteristic worth mentioning that has been 
observed in the VDR knockout mouse 
model. These mice show enhanced sen-
sitivity to both chemical carcinogenesis 
(Zinser et al., 2002) and UVR-induced 
tumor formation (Ellison et al., 2008). 
Interestingly, CYP27B1 knockout mice 
do not exhibit increased susceptibility 
to UV-elicited tumorigenesis (Ellison et 
al., 2008).Thus, in addition to playing 
key roles in epidermal and hair biology, 
VDR also seems to exhibit a tumor sup-
pressor function, apparently independent 
of binding of the 1,25(OH)2D3 ligand. 
Clearly, additional studies are needed to 
fully define the role(s) of the members of 
the vitamin D pathway in regulating vari-
ous aspects of skin physiology, as well as 
the involvement of these proteins in skin 
diseases, including alopecia. The report 
by Oda et al. represents a promising foray 
in this direction.
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Clinical Implications
•  There is evidence in humans of the importance of vitamin D and 
vitamin D receptor in skin biology.
•  Keratinocytes have the complete machinery to produce the active 
metabolite of vitamin D upon exposure of skin to UVR.
•  Patients with vitamin D–dependent rickets IIA may exhibit alopecia, 
suggesting a role for the vitamin D pathway in regulating hair follicle 
biology in humans.




markers in IFe Hair loss
MED1 KO (Oda et al., 2012) ↑ ↑ Yes
CYP27B1 KO (Bikle et al., 2004) No change ↓ No
VDR KO (Xie et al., 2002) No change ↓ Yes
VDR KO + high-calcium rescue diet  
(Li et al., 1998)
NR NR Yes
VDR KO + KC-VDR (Chen et al., 2001) NR NR No
VDR KO + KC-VDR with mutant ligand- 
binding domain (Skorija et al., 2005)
NR NR No
VDR KO + KC-VDR with mutant DNA  
binding domain (Skorija et al., 2005)
NR NR Yes
Hairless KO (Zarach et al., 2004) ↑ ↑ Yes
RXR conditional KO (Li et al., 2001) ↑ ↓ Yes
IFE, interfollicular epidermis; KC-VDR, keratinocyte-targeted VDR; KO, knockout; NR, not reported; 
VDR, vitamin D receptor.
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Homeward Bound: How Do Skin 
Dendritic Cells Find Their Way into 
the Lymph System?
Sam T. Hwang1
The success of the adaptive immune system relies upon the transport of 
antigens by dendritic cells (DCs) from skin via lymphatic vessels to lymph nodes 
where DCs present antigen to T cells.  Little is known about the requirements for 
so-called “reverse transmigration” (RT).  Torzicky et al. in this issue demonstrate 
that CD31, CD99, and CXCR4 play key roles in RT, suggesting that adhesion 
occurs in a defined sequence during the passage of DC into lymphatics.  
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The success of the adaptive immune 
system relies in part on the efficient 
transport of antigens by specialized 
antigen-presenting cells (e.g., dendrit-
ic cells (DCs) from barrier tissue such 
as skin (where infectious organisms 
first invade) to secondary lymphoid 
organs such as lymph nodes (LNs), 
where the DCs present antigen to naive 
and memory T cells (Randolph et al., 
2005). Although this process is critical 
for immune cell priming, much less is 
known about it, including the cyto-
kines and adhesion molecules that are 
required, than about the effector phase 
of adaptive immunity in which T cells 
(and other leukocytes) migrate from 
the blood stream to tissue by first tran-
siently stopping (rolling), firmly arrest-
ing, and finally crawling (diapedesis) 
between blood vascular endothelial 
cells (BVECs) to emerge on the tissue 
side of the blood vessel (Mackay, 1999).
Lymphatic vessels have long been 
appreciated in humans. Veiled cells 
resembling macrophages were iden-
tified more than 40 years ago in 
lymphatic fluid (Smith et al., 1970). 
These veiled cells were eventually rec-
ognized to be potent antigen-presenting 
cells called DCs; in skin, they are 
composed primarily of epidermal 
DCs called Langerhans cells (LCs) and 
dermal DCs.
The complex route of epidermal LCs 
has been of particular interest because 
these cells must leave the epidermis 
prior to entering lymphatic vessels. 
Migration of LCs appears to be associ-
ated with the activation of resting LCs 
by inflammatory triggers such as IL-1b 
and tumor necrosis factor-a. The latter 
two cytokines not only cause LCs to 
strongly upregulate major histocom-
patibility complex class II and costim-
ulatory molecules but also may induce 
the generation of lymphangiogenic 
cytokines such as vascular endothelial 
growth factor-C, which increase the 
number of lymphatic vessels at sites 
of inflammation. As LCs mature, 
they also downregulate expression 
of E-cadherin (Schwarzenberger and 
Udey, 1996), which may anchor 
LCs to keratinocytes in the epider-
mis and initiate expression of matrix 
metalloproteinases, allowing them to 
pass through the basement membrane 
(Angeli and Randolph, 2006).
Two key membrane receptors that 
are upregulated with LC/DC matura-
tion are the chemotactic receptors CC 
chemokine receptor-7 (CCR7) and 
CXC chemokine receptor-4 (CXCR4). 
The role of CCR7 and its two ligands 
(CCL19 and -21) in lymphatic traffick-
ing is better understood because CCR7-
deficient knockout mice (CCR7-KO) 
(Foerster et al., 1999) and paucity of LN 
T cells (plt) mice (Gunn et al., 1999), 
which lack expression of select CCR7 
chemokine ligands (CCL19/21) at the 
periphery and within LNs, both exhibit 
small peripheral LNs. This phenotype 
